Pre-dementia neurocognitive disorder: diagnostic and therapeutic aspects

Pre-dementia neurocognitive disorder: diagnostic and therapeutic aspects

There are the concept of mild cognitive decline (Mild cognitive impairment - MCI) and current approaches to the diagnosis pre-dementia (symptomatic) stage of Alzheimer’s disease in this discussing article. The article highlights previously attempts of preventive treatment of dementia due to Alzheime...

Full description

Bibliographic Details
Main Author:	S. I. Gavrilova
Format:	Article
Language:	Russian
Published:	Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation 2018-07-01
Series:	Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Subjects:	мягкое когнитивное снижение болезнь альцгеймера мониторинг терапии цитиколин церебролизин mild cognitive impairment alzheimer’s disease monitoring therapy citicoline сerebrolysin
Online Access:	https://www.bekhterevreview.com/jour/article/view/133

Similar Items

Retinal nerve fiber layer and ganglion cell complex thickness assessment in patients with Alzheimer disease and mild cognitive impairment. Preliminary results
by: A. S. Tiganov, et al.
Published: (2014-07-01)

Cognitive disorders and therapy in patients with hypertension
by: N. V. Vakhnina
Published: (2014-12-01)

Alzheimer’s disease with an early debut
by: N. N. Koberskaya, et al.
Published: (2019-03-01)

Is Citicoline Effective in Preventing and Slowing Down Dementia?—A Systematic Review and a Meta-Analysis
by: Maria Bonvicini, et al.
Published: (2023-01-01)

Poststroke cognitive impairment and dementia
by: D. V. Sergeev, et al.
Published: (2016-12-01)

Some aspects of treatment of neurodegenerative dementias
by: I. S. Preobrazhenskaya, et al.
Published: (2014-12-01)

Гепатит С увеличивает риск болезни Паркинсона
by: Editorial Article
Published: (2015-12-01)

Comparative characteristics of enzymatic antioxidant protection in patients with mild cognitive decline and late-onset depression. Is a therapeutic correction possible?
by: N. M. Zalutskaya, et al.
Published: (2018-07-01)

Alzheimer's disease: from theory to practice
by: А. S. Kotov, et al.
Published: (2015-12-01)

Post-stroke cognitive impairment and treatment options
by: A. N. Bogolepova
Published: (2015-12-01)

Клинико-экономические аспекты терапии болезни Альцгеймера в России
Published: (2018-06-01)

Some aspects of the background symptomatic treatment of cognitive impairment of various severity types
by: I. S. Preobrazhenskaya
Published: (2013-12-01)

Treatment of brain injury
by: A. E. Talypov, et al.
Published: (2013-12-01)

Clinical efficacy of long-term treatment in patients with vascular dementia
by: I. A. Suvorova
Published: (2011-04-01)

Cognitive impairment of neurodegenerative diseases
by: V. V. Zakharov, et al.
Published: (2013-12-01)

Functional analysis and signaling pathway enrichment analysis of genes associated with Alzheimer’s disease and Parkinson’s disease
by: N. Yu. Chasovskikh, et al.
Published: (2020-04-01)

Using of cerebrolysin in patients with epilepsy
by: A. S. Kotov
Published: (2018-04-01)

ОЦЕНКА ЭФФЕКТИВНОСТИ ИСПОЛЬЗОВАНИЯ НЕЙРОПСИХОЛОГИЧЕСКИХ ШКАЛ В ДИАГНОСТИКЕ ПРЕДДЕМЕНТНЫХ И ДЕМЕНТНЫХ РАССТРОЙСТВ У ПАЦИЕНТОВ С БОЛЕЗНЬЮ АЛЬЦГЕЙМЕРА
by: А. А. Лакутин, et al.
Published: (2024-01-01)

Aberrant angiogenesis in brain tissue in experimental Alzheimer’s disease
by: Ya. V. Gorina, et al.
Published: (2021-01-01)

The effect of insulin resistance on amygdale glucose metabolism alterations in experimental Alzheimer’s disease
by: Ya. V. Gorina, et al.
Published: (2018-01-01)

Когнитивные расстройства позднего возраста
by: Виктор Степанович Мякотных, et al.
Published: (2022-02-01)

Use of the voxel-based morphometry method in the diagnosis of dementia of the Alzheimer type
by: E. . Andreev, et al.
Published: (2018-07-01)

Antihypertension drugs in prevention of cognition disorder and dementia: focus on calcium channel blockers and diuretics
by: O. D. Ostroumova, et al.
Published: (2018-10-01)

Citicoline for ischemic stroke: from acute phase to rehabilitation
by: D. V. Sergeev, et al.
Published: (2015-12-01)

The dynamics of the cognitive and social functioning of patients with Alzheimer’s disease on therapy with antidementiv drugs: the results of observational study
by: N. M. Zalutskaya, et al.
Published: (2018-07-01)

Infectious agents as a risk factor for Alzheimer’s disease
by: S. V. Vorobyev, et al.
Published: (2020-03-01)

MORPHOLOGICAL CHANGES IN THE HIPPOCAMPUS OF RATS IN ACCELERATED AGING
by: K. Yu. Maksimova, et al.
Published: (2014-02-01)

The hippocampus as a structural and functional network epicentre for distant cortical thinning in neurocognitive aging
by: Billaud, Charly Hugo Alexandre, et al.
Published: (2024)

Cognitive impairment in COVID-19 survivors
by: T. M. Ostroumova, et al.
Published: (2021-02-01)

Management of patients after ischemic stroke. Use of citicoline
by: V. A. Parfyonov
Published: (2014-12-01)

Сerebrolysin® influences in Sod- and sws-dependent neurodegenerative models of Drosophila melanogaster
by: Nataliya Matiytsiv, et al.
Published: (2023-06-01)

Major Vascular Neurocognitive Disorder: A Reappraisal to Vascular Dementia
by: Emre Kumral, et al.
Published: (2017-03-01)

Apathy and APOE in mild behavioral impairment, and risk for incident dementia
by: Daniella Vellone, et al.
Published: (2022-01-01)

Language in Amnestic Mild Cognitive Impairment and Dementia of Alzheimer’s Type: Quantitatively or Qualitatively Different?
by: Regina Jokel, et al.
Published: (2019-03-01)

Practice guidelines for monitoring the safety of tofacitinib (according to the proceedings of the Expert Council resolution dated 14 October 2014, Moscow)
by: Article Editorial
Published: (2015-09-01)

Bioinformatic analysis of biological pathways in coronary heart disease and Alzheimer’s disease
by: N. Y. Chasovskikh, et al.
Published: (2023-01-01)

Tangram Puzzles in Patients with Neurocognitive Disorders: A Pilot Study
by: Jian Zhang, et al.
Published: (2023-12-01)

Dendritic Branching of Retinal Ganglion Cells as a Biomarker of Glaucomatous Optic Neuropathy and Alzheimer’s Disease and a Target of Neuroprotective Therapy
by: M. V. Zueva, et al.
Published: (2021-07-01)

Dendritic Branching of Retinal Ganglion Cells as a Biomarker of Glaucomatous Optic Neuropathy and Alzheimer’s Disease and a Target of Neuroprotective Therapy
by: M. V. Zueva, et al.
Published: (2022-10-01)

Characteristics of brain cell proliferation and migration in animals with experimental Alzheimer’s disease undergoing cognitive training
by: Yu. K. Komleva, et al.
Published: (2017-01-01)